Company Filing History:
1 out of 111 
1 out of 1,309 
1 out of 5,309 
Years Active: 2015
Title: William I. Weis: Innovator in Hybrid Amyloid-Beta Antibodies
Introduction
William I. Weis is a notable inventor based in Palo Alto, CA, recognized for his contributions to the field of biochemistry and immunology. With a focus on developing innovative solutions for health-related challenges, he has successfully secured a patent for his groundbreaking work involving hybrid amyloid-beta antibodies.
Latest Patents
William I. Weis holds a patent that centers on hybrid amyloid-beta antibodies. The invention encompasses various aspects, including crystals composed of specific amino acids and Fab fragments. The key features of his patent include methods for preparing these crystals and a computer-implemented technique for analyzing the binding of candidate antibody fragments to peptides. Additionally, the patent outlines methods for identifying and designing antibody fragments that can bind to specific epitopes, particularly those associated with Alzheimer's disease.
Career Highlights
Throughout his career, William I. Weis has made significant strides in the biotechnology sector. He has been affiliated with notable companies such as Janssen Sciences Ireland UC and Wyeth, contributing his expertise in the evolution of innovative antibody therapies. His work has broad implications for therapeutic approaches aimed at treating neurodegenerative disorders.
Collaborations
William has collaborated with esteemed colleagues, including Guriqbal Basi and Dale Bernard Schenk. These partnerships have further propelled his research endeavors and have led to advancements in the understanding and treatment of amyloid-related diseases.
Conclusion
William I. Weis exemplifies the spirit of innovation through his commitment to developing advanced therapeutic solutions. His patent on hybrid amyloid-beta antibodies is a testament to his dedication to improving the understanding and treatment of critical health issues. As he continues to push the boundaries of science, his work will undoubtedly impact the field of immunology for years to come.